GEN Exclusives

More »

Tech Notes

More »
Jun 15, 2010 (Vol. 30, No. 12)

Rapid Identification of Production Strains

Accelerating Protein Concentration and Functional Analyses to Improve Efficiency

  • Click Image To Enlarge +
    Figure 1. The Octet platform consists of Octet RED384 and QK384 systems that provide 16-channel simultaneous read-out, two microplate positions, 96- and 384-well plate formats and automation compatibility, and Octet RED, QKe, and QK systems that provide eight-channel simultaneous read-out and 96-well microplate format.

    Accurate protein quantitation is critical to the selection of expression strains for development and optimization of bioreactor titers in production. Traditional analytical methods include ELISA, HPLC, nephelometry, and densitometry. Drawbacks to these methods include long analysis times, lack of specificity, labor-intensive protocols, and imprecision.

    Label-free assays offer an ideal solution for reducing bioprocessing bottlenecks and ensuring high product quality and improved efficiencies.

    This tutorial describes the use of ForteBio’s Octet instruments and Dip and Read™ biosensor assays in the protein expression workflow at Pfenex. Previously a business unit of Dow Chemical, Pfenex was recently spun-off as a separate entity, specializing in protein expression strain engineering and process development using high-throughput, parallel processing that is robotically enabled and relies upon Pfenex Expression Technology™, a Pseudomonas fluorescens-based system.

    ForteBio’s Octet family of instruments provides analysis of antibodies and other therapeutic proteins (Figure 1). Its analytical capabilities have applications where existing methods such as HPLC and ELISA have limitations in throughput, performance, time-to-result, and ease of use.

    With full-plate protein quantitation in 15 to 30 minutes, Octet systems provide direct label-free quantitation of antibodies or other proteins that are critical to early cell culture screening, protein purification, cell-line selection for optimization of antibody production, and biologics manufacturing.

    Octet systems utilize BioLayer Interferometry (BLI) technology to monitor the binding of proteins and other biomolecules to their partners directly, in real time. The binding interaction is continuously monitored by measuring the change in thickness of the protein layer on the tip of a biosensor. The method does not require  labeling of the protein with fluorescent or chromogenic tags, thus eliminating interference issues.

    A variety of Dip and Read biosensor chemistries are available off-the-shelf such as protein A, antihuman and antimurine IgG, antipenta-HIS, streptavidin, and custom biosensors specific for a program or analyte that can facilitate the rapid development of assays for IgG and other proteins. These biosensors measure protein concentration in the presence of extraneous matter such as cell debris, which is typically present in cell lysates and cell culture supernatants, thus providing rapid titer measurements without laborious sample preparation.

    Octet software provides multiple curve fits, exports reports to Excel, and automates batch-mode data analysis.

  • Click Image To Enlarge +
    Figure 2. Pfenex Expression Technology HTP growth, expression, and analysis workflow

    While the Octet platform can enable fast titer measurements, Pfenex Expression Technology can help accelerate development of protein leads into clinical studies by assuring first time, significant production of virtually any aglycosylated protein in a scalable system within five weeks. Specific components of the platform were designed to ensure soluble and active expression through the avoidance of proteolytic clipping and post-translational modifications along with enhancements to solubility through protein-folding improvements.

    The Pfenex Expression Technology platform has been constructed to assess the performance of thousands of host strain/plasmid combinations in parallel to rapidly identify production strains for proteins that  cannot be expressed in any other system. Host strains include those with one or more deletions in protease genes, co-expression of folding modulator proteins, proteins involved in disulfide bond creation, along with combinations of these.

    Genetic control elements on expression plasmids (promoters, ribosome binding sites, secretion leaders) have been combined to generate >100 off-the-shelf, unique, rapid cloning vectors, allowing control of protein expression and quality.

    Predicting which components will be crucial in successful expression of any given protein cannot be determined from intrinsic information such as amino acid sequence. This means that the combination of critical factors is empirical for each individual target protein. Accordingly, Pfenex has developed a high-throughput, robotically enabled screening work process in 96-well format. This process is coupled to high-throughput analytical methods such as the Octet system, which allows the parallel evaluation of hundreds of unique host strains containing a variety of expression strategies for a specific gene (Figure 2).



Related content

Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...
More »

GEN Poll

More » Poll Results »

Eyes on the Science Prizes

The proliferation of big-money science prizes might be seen as cheering or worrisome. Where do you stand?